Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

NCT04686643 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: AGSAVI
DRUG: AGLS

Sponsor

Ahn-Gook Pharmaceuticals Co.,Ltd